Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196310 · ClinicalTrials.gov registry record · NA
Single Blinded First CMC Osteoarthritis Treatment
A NA study of Osteoarthritis Thumb, sponsored by Kettering Health Network.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03196310 is a NA study of Osteoarthritis Thumb that is actively recruiting participants, run by Kettering Health Network. The registered enrollment target is 150 participants, below the 429-participant average among 3 other Osteoarthritis Thumb trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03196310, a NA study of Osteoarthritis Thumb, is actively recruiting participants, sponsored by Kettering Health Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
Conditions Studied
Interventions
- OTHER Normal Saline
- DRUG Platelet Concentrate
- DRUG Corticosteroid injection
Study Locations (1)
Ohio
- Orthopedic Associates of Southwest Ohio - Centerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03196310
The ClinicalTrials.gov registry entry for NCT03196310 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 429-participant average among 3 other Osteoarthritis Thumb trials with a reported enrollment target (65% lower). The listed sponsor is Kettering Health Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis Thumb appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.
NCT03196310 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03196310 about?
NCT03196310 is a clinical study titled "Single Blinded First CMC Osteoarthritis Treatment". Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.
What is the current status of trial NCT03196310?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-09-01. Estimated completion is 2025-03-31.
What conditions does trial NCT03196310 study?
This clinical trial studies the following conditions: Osteoarthritis Thumb.
What interventions are being tested in trial NCT03196310?
The interventions under investigation include: Normal Saline (OTHER), Platelet Concentrate (DRUG), Corticosteroid injection (DRUG).
Who is sponsoring clinical trial NCT03196310?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03196310 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Thumb
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.